XML 19 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2020
Cash flows from operating activities    
Net loss $ (31) $ (41,693)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 0 3
Change in fair value of preferred stock tranche liability 0 17,030
Research and development license expense 0 6,000
Stock-based compensation 0 1,341
Changes in operating assets and liabilities:    
Prepaid expenses 0 (604)
Accounts payable 0 5,403
Accrued expenses 31 1,579
Due to related party 0 60
Net cash used in operating activities 0 (10,881)
Cash flows from investing activities    
Purchase of research and development license 0 (3,000)
Purchase of property and equipment 0 (31)
Net cash used in investing activities 0 (3,031)
Cash flows from financing activities    
Proceeds from issuance of common stock in initial public offering, net of underwriting discounts and commission and other offering costs 0 167,162
Proceeds from notes payable to related party 0 1,673
Repayment of notes payable to related party 0 (1,673)
Net cash provided by financing activities 0 292,546
Net increase in cash and cash equivalents 0 278,634
Cash at the beginning of the period 0  
Cash at the end of the period 0 278,634
Supplemental disclosure of cash flow information:    
Cash paid for interest 0 28
Supplemental disclosure of noncash investing and financing activities:    
Reclassification of preferred stock tranche liability upon share issuance 0 18,080
Allocation of preferred stock tranche liability 0 1,050
Conversion of Series A and Series B convertible preferred stock to common stock 0 142,240
Purchase of research and development license not yet paid 0 3,000
Series A Convertible Preferred Stock    
Cash flows from financing activities    
Proceeds from issuances of convertible preferred stock, net of issuance costs 0 29,569
Supplemental disclosure of noncash investing and financing activities:    
Issuance costs for issuances of stock not yet paid 0 174
Series B Convertible Preferred Stock    
Cash flows from financing activities    
Proceeds from issuances of convertible preferred stock, net of issuance costs 0 95,815
Common Stock    
Supplemental disclosure of noncash investing and financing activities:    
Issuance costs for issuances of stock not yet paid $ 0 $ 1,273